The Celgene logo represents the visual identity of Celgene Corporation, a biopharmaceutical company that was headquartered in Summit, New Jersey. Founded in 1986 as a spin-off from Celanese Corporation, Celgene grew into one of the largest biotech firms in the world before Bristol-Myers Squibb acquired it in 2019 for approximately $74 billion.
The logo featured an abstract symbol paired with a clean wordmark, rendered primarily in blue. It went through refinements during the company’s 33-year run as an independent entity, with the most recent version introduced around March 2018. The mark became closely associated with blockbuster drugs like Revlimid and Pomalyst, and it carried significant recognition across oncology and hematology circles.
Celgene only used one primary logo design during its existence, though it received subtle updates over the decades. The brand is now part of the Bristol-Myers Squibb corporate family.
What Is the Celgene Logo?

The Celgene logo is a combination mark featuring an abstract interlocking symbol above the “celgene” wordmark, rendered in deep blue. It was used from 1986 until the company’s acquisition by Bristol-Myers Squibb in November 2019, with its final version introduced in March 2018.
Here’s a breakdown of the logo’s key details:
- Design Type: Combination mark (abstract symbol plus wordmark)
- Primary Elements: An abstract interlocking graphic that references molecular structures and scientific collaboration, positioned above the company name in lowercase lettering
- Official Introduction Date: 1986 (original); March 2018 (final version)
- Designer/Agency: Not publicly disclosed. The European corporate identity was handled by CCHE for Celgene’s Boudry, Switzerland office in 2007
- Trademark Status: Registered trademark of Celgene Corporation, now owned by Bristol-Myers Squibb
- Color Palette: Deep blue (#1C3B7E) as the primary color, with green accents used in certain brand applications
- Usage Context: Drug packaging, clinical trial documentation, corporate reports, investor presentations, digital platforms, and marketing materials across oncology and immunology products
How Has the Celgene Logo Evolved Over Time?

The Celgene logo stayed relatively consistent throughout the company’s history. Unlike many pharmaceutical company brands that undergo dramatic redesigns every few years, Celgene kept things tight.
The original mark established the blue color and abstract symbol from the start. Refinements happened gradually, with the most visible update arriving in March 2018.
Original Celgene Logo (1986 – 2018)
When Celgene spun off from Celanese in 1986, it needed its own identity fast. The company was initially focused on bioremediation, not pharmaceuticals. But the logo had to suggest science and precision regardless.
Years Active: 1986 – 2018
The early mark used blue tones and an abstract graphic element. It was simple. Maybe too simple for what the company would eventually become, but it worked.
The color palette leaned heavily on a dark blue. This made sense for a company operating in healthcare, where trust and reliability are everything.
At this point, Celgene was still a small operation. It posted just $2.3 million in sales in 1988. The logo needed to punch above its weight, and the clean design managed that. Once the company acquired the rights to thalidomide in 1992 and pivoted hard into pharmaceuticals, the existing brand identity carried over without major changes.
In 2007, CCHE designed a visual identity for Celgene’s European operations in Boudry, Switzerland. They took the original logo’s abstract shape, duplicated it, and combined elements to form a molecular pattern. That molecule motif showed up everywhere, from office murals to stationery to the parking lot entrance. It was a clever extension of the existing brand without actually changing the logo itself.
Updated Celgene Logo (March 2018 – 2019)
The final version of the Celgene logo appeared in March 2018. This was right around the time the company acquired Juno Therapeutics for $9 billion, which was a massive move.
Years Active: March 2018 – November 2019
The updated design refined the abstract interlocking symbol and cleaned up the wordmark. The core concept stayed the same. The deep blue (#1C3B7E) remained the primary hue.
Green accents appeared in some applications, suggesting growth and vitality. The overall look felt more polished, more confident. This was a $13 billion revenue company by then, so the brand needed to match that scale.
The timing is worth noting. Bristol-Myers Squibb announced its acquisition of Celgene in January 2019, less than a year after this refresh. So the updated logo didn’t get much time in the spotlight as an independent identity.
Once the $74 billion acquisition closed in November 2019, the Celgene brand was gradually absorbed into Bristol-Myers Squibb’s corporate identity. The celgene.com domain now redirects to the BMS website.
What Do the Design Elements of the Celgene Logo Mean?

The Celgene logo’s abstract symbol suggests molecular structures and interconnected systems. It reflects the company’s core work in drug discovery, where understanding molecular interactions is the whole game.
The interlocking shapes also imply collaboration, which tracks with Celgene’s approach to partnerships and acquisitions throughout its history.
Why Did Celgene Choose These Specific Colors?
Blue is the default for pharma and biotech. Look at Pfizer, Novo Nordisk, and dozens of others. There’s a reason for that.
According to color psychology, blue communicates trust, stability, and professionalism. For a company developing cancer treatments, those are exactly the signals you want to send.
Celgene’s primary blue sits at #1C3B7E, which is a deep, almost navy tone. The RGB values are (28, 59, 126). It’s darker than what you see from companies like Salesforce or Zoom, which use brighter blues. That darkness adds gravity. It feels serious.
Green accents showed up in secondary brand materials. Green hints at life, health, and renewal, which is appropriate for a company focused on oncology and immunology therapeutics.
What Typography Style Is Used in the Celgene Logo?
The Celgene wordmark uses a sans-serif typeface set in all lowercase. The specific font appears to be custom or heavily modified, which is common for pharma companies at this scale.
The lowercase treatment is an interesting choice. It softens the brand, making it feel more approachable. Most pharmaceutical companies go uppercase. Celgene didn’t.
The letterforms are clean and evenly spaced, with generous tracking between characters. Readability was clearly a priority, which makes sense when your logo appears on everything from pill bottles to SEC filings.
What Are the Hidden Meanings in the Celgene Logo?
The abstract symbol at the top of the logo can be read as interlocking elements forming a unified whole. Some see molecular bonds. Others see two entities coming together, which (in retrospect) feels a bit prophetic given the BMS acquisition.
The European office took this further in 2007 by duplicating the logo’s shapes into full molecular patterns. That suggests even Celgene itself saw the abstract mark as fundamentally molecular in nature.
There’s no publicly available statement from Celgene’s design team about hidden meanings or deliberate shape symbolism. But the interplay of forms clearly points to scientific partnership and connected research.
How Does the Celgene Logo Compare to Competitor Logos?

The pharmaceutical industry is, let’s be honest, not exactly a hotbed of logo creativity. Most companies settle on blue, add an abstract mark, and call it a day.
Celgene fit that pattern. But it did have distinguishing features.
Compared to Amgen, which uses a bold wordmark with a distinctive “A” construction, Celgene’s logo was more understated. The Biogen logo goes for a similar abstract-plus-wordmark approach but uses a different color range. AbbVie took a completely different path with its split-name treatment.
Where Celgene stood out was in the lowercase wordmark. That’s still unusual for Big Pharma. Companies like Merck, Roche, and Novartis all use capitalized or title-case branding. Celgene’s lowercase felt more like a tech company than a drug maker, and that was probably intentional. It positioned the company as modern and forward-looking within an industry that can feel pretty old-school.
What Are the Technical Specifications of the Celgene Logo?
Official Color Codes
- Primary Color: Celgene Blue
- Hex: #1C3B7E
- RGB: (28, 59, 126)
- CMYK: (78, 53, 0, 51) approximately
- Secondary Color: White
- Hex: #FFFFFF
- Used for reversed applications on dark backgrounds
- Accent Color: Green
- Used in select brand materials for secondary emphasis
Dimensions and Proportions
The logo’s SVG file on Wikimedia Commons is nominally 166 x 146 pixels, giving it a near-square aspect ratio. The abstract symbol sits above the wordmark, roughly splitting the vertical space.
The original logo file is 12 KB as an SVG, which is compact. This matters for web applications where load speed counts.
Standard brand guidelines for pharmaceutical logos typically require clear space equal to a defined unit (often the height of the “C” in the wordmark) on all sides. Celgene followed similar conventions, though their specific guidelines aren’t publicly available post-acquisition.
The logo was distributed as vector graphics (SVG, AI, EPS) for scalable use across print and digital, and as raster formats (JPEG, PNG) for general use.
What Cultural Impact Has the Celgene Logo Had?

The Celgene logo became synonymous with breakthrough cancer therapies, particularly Revlimid, which transformed the treatment of multiple myeloma. For patients and oncologists, that mark carried weight.
It was also a fixture on Wall Street. Celgene traded on NASDAQ under the ticker CELG, and the logo appeared in countless financial reports, analyst presentations, and investor materials. At its peak, the company was a component of both the NASDAQ-100 and the S&P 500.
The $74 billion acquisition by Bristol-Myers Squibb in 2019 made it one of the largest pharmaceutical deals in history. The Celgene logo appeared prominently in all press coverage of that transaction. In that moment, the logo represented not just a company but an entire era of biotech growth.
How Does the Celgene Logo Fit Into the Overall Brand Identity?
The logo was the anchor point for everything Celgene did visually. From clinical trial materials to its annual report, from drug packaging to conference booth designs, the mark provided consistency.
Celgene’s brand style extended the logo’s blue palette across all touchpoints. The molecular motif developed for the European offices in 2007 became a secondary brand element, showing how the abstract logo symbol could generate a full visual language.
After the Bristol-Myers Squibb acquisition, the Celgene brand was gradually retired. Products like Revlimid and Pomalyst continued under BMS branding. The Celgene name now exists primarily in historical and legal contexts.
How Should the Celgene Logo Be Used?
Since Bristol-Myers Squibb completed its acquisition in November 2019, use of the Celgene logo is restricted. The brand is no longer active as an independent entity.
Key points on usage:
- The Celgene logo is a registered trademark now owned by Bristol-Myers Squibb
- The celgene.com domain redirects to the Bristol-Myers Squibb corporate website
- Historical or editorial use of the logo (in articles, case studies, or academic research) is generally acceptable under fair use provisions
- Commercial use of the Celgene logo without permission from BMS is not allowed
- Official logo files were previously available through Celgene’s media library, but that resource is no longer maintained independently
- Vector versions of the logo remain available on third-party logo databases in SVG, AI, and EPS formats
If you need to reference the Celgene brand for any official purpose, contact Bristol-Myers Squibb’s communications or legal team directly. The trademark protections remain in place even though the brand is no longer in active commercial use.
FAQ on The Celgene Logo
What does the Celgene logo look like?
The Celgene logo is a combination mark with an abstract interlocking symbol above a lowercase wordmark. It uses deep blue (#1C3B7E) as its primary color. The abstract graphic suggests molecular structures, tying the visual identity directly to the company’s biopharmaceutical focus.
When was the Celgene logo first introduced?
Celgene Corporation adopted its original logo in 1986 when the company spun off from Celanese. The final updated version appeared in March 2018. That refresh came just months before Bristol-Myers Squibb announced the acquisition in January 2019.
Who designed the Celgene logo?
The original designer has never been publicly identified. For the European corporate identity in 2007, CCHE handled the visual branding at Celgene’s Boudry, Switzerland office. They built a molecular motif from the existing logo symbol.
What do the colors in the Celgene logo mean?
The deep blue communicates trust and professionalism, which is standard across pharmaceutical branding. Green accents in secondary materials suggest vitality and growth. These color choices align with the oncology and immunology focus of the company.
Is the Celgene logo still in use?
Bristol-Myers Squibb acquired Celgene in November 2019 for $74 billion. The Celgene brand was gradually retired after the deal closed. The celgene.com domain now redirects to the BMS corporate website, and the logo is no longer used commercially.
What font is used in the Celgene logo?
The wordmark uses a clean sans-serif typeface in all lowercase. It appears to be custom or heavily modified. The generous letter spacing and simple letterforms prioritize readability across drug packaging, clinical documents, and digital platforms.
What is the symbolism behind the Celgene logo?
The interlocking abstract shapes reference molecular bonds and collaborative research. Celgene’s European offices expanded this into full molecular patterns in 2007. The mark reflects the company’s work in drug discovery, particularly in hematology and oncology therapeutics.
How does the Celgene logo compare to other pharma logos?
Most pharmaceutical companies use blue with abstract marks. Celgene’s lowercase wordmark set it apart from competitors like Eli Lilly and Sanofi, which use capitalized text. The approach felt closer to tech company branding than traditional pharma.
Can I download the Celgene logo for my project?
Vector files in SVG, AI, and EPS formats exist on third-party logo databases. The trademark is owned by Bristol-Myers Squibb. Editorial and academic use typically falls under fair use, but commercial use requires permission from BMS.
What happened to the Celgene brand after the acquisition?
After the $74 billion acquisition, Celgene products like Revlimid and Pomalyst continued under Bristol-Myers Squibb branding. The Celgene name exists now in historical and legal contexts only. The corporate identity was fully absorbed into the BMS brand system.
Conclusion
The Celgene logo carried a lot of weight for a mark that looked deceptively simple. It represented a company that grew from a $2.3 million bioremediation outfit into a Fortune 500 pharmaceutical giant with $13 billion in annual revenue.
That deep blue abstract symbol and lowercase wordmark became shorthand for breakthrough cancer treatments like Revlimid and Pomalyst across the global oncology community.
Even though the brand disappeared after the Johnson & Johnson-rivaling Bristol-Myers Squibb acquisition in 2019, the corporate identity left its mark on biotech branding as a whole.
It proved that a pharma company could look modern and approachable without sacrificing credibility. Not every drug maker pulled that off.
- The Airtable Logo History, Colors, Font, And Meaning - 12 July 2026
- How to Blur Background in Canva: A Quick Tutorial - 11 July 2026
- Typography Trends - 10 July 2026